Clinical Professor
Board Certified Gynecologic Oncologist
Contact Information:
| Mailing Address: |
Division of Gynecologic Oncology |
| Academic Phone: | 415-885-7204 / 415-885-7561 |
| Academic Fax: |
415-885-3586 |
Research/Clinical Interests
Stefanie Ueda's primary interest is in global health as well as clinical capacity building in low middle income countries. During the last 9 years, she has helped to start the first gynecologic oncology fellowship in Uganda to improve complex surgical skill development and multidisciplinary care at the country's only cancer institute and largest public hospital. The first two in-country fellows graduated in October 2019. The program has gained recognition from the Society of Gynecologic Oncology and the International Gynecologic Cancer Society, with the hopes expanding access for women with gynecologic malignancies in sub-Saharan Africa. Dr. Ueda took on the role of gynecologic oncology fellowship director at UCSF in July 2020.
Education/ Training
| Year | Institution & Location | Degree | Field of Study |
|---|---|---|---|
| 1997 | Stanford University, Stanford, CA | B.A. | English |
| 2002 | New York University School of Medicine, New York, NY | M.D. | Medicine |
| 2006 | University of Hawaii, Honolulu, HI | Residency | Obstetrics & Gynecology |
| 2010 | Johns Hopkins School of Medicine, Baltimore, MD | Fellowship | Gynecologic Oncology |
Achievements & Recognition
| Year | Major Honors |
|---|---|
| 2007 |
HERA Foundation Award in Ovarian Cancer Research |
| 2007 |
Entertainment Industry Foundation Award in Ovarian Cancer Research |
Ueda SM, Yap, KL, Davidson, B et al. Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas. J Oncology 2010;2010:285191.
Krill LS, Ueda SM, Gerardi M, Bristow RE. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Article in press for Gynecol Oncol. 2011 Feb; 120(2):220-3
Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Nickles-Fader A. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol 2001;55(3):255-60.
Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol 2011;122(2):319-23.
Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I non-invasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer 2012;22(2):273-9.